non-coding RNA/protein/gene | Source | Expression pattern | Action target/pathway | Outcome | References |
---|---|---|---|---|---|
a. Promote cancer progression | |||||
 miR-27b-3p | Tumor | Upregulated | VE-Cad, p120 | Increase vascular permeability; Promote the generation and metastasis of CTCs | [30] |
 miR-25-3p, miR-130b-3p, miR-425-5p, miR-934 | Tumor | Upregulated | KLF2, KLF4, PI3K / Akt, PTEN | Angiogenesis; M2 polarization of macrophages | |
 miR-146a-5p, miR-155-5p | Tumor | Upregulated | SOCS1, ZBTB2 | Promote activation of CAFs; Induction of EMT | [22] |
 miR-181a-5p | Tumor | Upregulated | SOCS3, IL6/STAT3 | Activate HSC; PMN formation | [32] |
 miRNA-106b-5p, miR-106b-3p | Tumor/serum | Upregulated | PDCD4, DLC-1 | M2 polarization of macrophages; Accelerated metastasis; Induction of EMT | |
 miR-135a-5p, miR-25 | Tumor | Upregulated | LATS2 /YAP1 / MMP7, SIRT6 | PMN formation; Liver metastases | |
 miR-221-3p, miR-221/222 | Tumor/serum | Upregulated | SOCS3, SPINT1 | Angiogenesis; Liver metastases; PMN formation | |
 miR-128-3p | Tumor | Upregulated | FOXO4, TGF-β / SMAD, JAK / STAT3 | Induction of EMT | [20] |
 miR-17-5p | CAF | Upregulated | RUNX3/ MYC / TGF-β1 | Accelerated metastasis | [101] |
 miR-92a-3p | CAF | Upregulated | Wnt / β-catenin, FBXW7, MOAP1 | Inhibit mitochondrial apoptosis to promote cell stemness, EMT, metastasis, and 5-FU / OX resistance | [47] |
 miR-21-5p, miR-155-5p | TAM | Upregulated | BRG1 | Promote CRC cell migration and invasion | [102] |
 miR-1229 | Serum | Upregulated | HIPK2 | Angiogenesis; Accelerated metastasis | [16] |
 circPACRGL | Tumor | Upregulated | miR-142-3p, miR-506-3p | Accelerated metastasis; Promotion of N1 to N2 differentiation of neutrophils | [103] |
 circLONP2 | Tumor | Upregulated | DDX1, DGCR8 / Drosha | Accelerated metastasis | [104] |
 circ-133 | plasma | Upregulated | miR-133a / GEF-H1 / RhoA | Accelerated metastasis | [105] |
 circ-ABCC1 | Tumor | Upregulated | Wnt / β-catenin | Accelerated metastasis | [106] |
 circEIF3K | CAF | Upregulated | miR-214 | Accelerated metastasis | [107] |
 lncRNA RPPH1, lncRNA HLA-F-AS1 | Tumor | Upregulated | TUBB3, miR-375 | Induction of EMT; M2 polarization of macrophages; Accelerated metastasis | |
 lncRNA MALAT1 | Tumor | Upregulated | miR-26a/26b, FUT4, PI3K / Akt / mTOR | Accelerated metastasis | [110] |
 HSPC111 | Tumor | Upregulated | ACLY | PMN formation; Liver metastasis | [13] |
 IRF-2 | Tumor | Upregulated | VEGFC | To guide tumor metastasis in SLN | [111] |
 PrPC | Tumor | Upregulated | - | Angiogenesis; Accelerated metastasis | [112] |
 Gas6, DPP4 | Tumor | Upregulated | Axl, Twist1, Smad pathway | Angiogenesis | |
b. Inhibit cancer progression | |||||
 miR-1255b-5p | Tumor | Downregulated | hTERT | Inhibit EMT; Inhibit metastasis | [21] |
 miR-193a-5p | plasma | Downregulated | CUX1, ITSN1 | Inhibit metastasis | [88] |
 miR-3940-5p | MSC | Upregulated | ITGA6 | Inhibit EMT; Inhibit metastasis | [115] |
 miR-203a-3p | Hepatocyte | – | E-cadherin, Src | Inhibit metastasis | [33] |
 circRHOBTB3 | Tumor | Downregulated | ENO1, ENO2 | Inhibition of EMT; Tumor suppressor | [116] |
 ANGPTL1 | Tumor | Downregulated | JAK2 / STAT3 | Inhibit liver metastasis; Block vascular leakage | [34] |